Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma

✍ Scribed by Gaetano Corazzelli; Gaetana Capobianco; Manuela Arcamone; Pier Ferruccio Ballerini; Emilio Iannitto; Filippo Russo; Ferdinando Frigeri; Cristina Becchimanzi; Gianpaolo Marcacci; Annarosaria De Chiara; Antonio Pinto

• Publisher: Springer
• Year: 2009
• Tongue: English
• Weight: 455 KB
• Volume: 64
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-009-0941-9